Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
140 Riverside Dr 1 O
New York, NY 10024Phone+1 212-678-9508Fax+1 212-543-6018
Education & Training
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1992 - 1996
- George Washington University School of Medicine and Health SciencesClass of 1992
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteFellowship, Addiction Psychiatry
Certifications & Licensure
- NY State Medical License 1993 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone Start of enrollment: 2007 Sep 01
- Improved Strategies for Outpatient Opioid Detoxification Start of enrollment: 2011 Jun 01
- Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPatient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials.Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, Sarah C Akerman, James Fratantonio
Drug and Alcohol Dependence. 2022-04-01 - 1 citationsCharacteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a resident...Paolo Mannelli, Antoine B Douaihy, Sarah C Akerman, Anna Legedza, James Fratantonio
The American Journal on Addictions. 2022-03-01 - 1 citationsPatterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.Paolo Mannelli, Antoine Douaihy, Abigail Zavod, Anna Legedza, Sarah C. Akerman
The American Journal of Drug and Alcohol Abuse. 2021-11-09
Journal Articles
- American Psychiatric Association PublishingAdam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health
Press Mentions
- Did the Pandemic Give a Bunch of Men “Dad Bods” Again?May 10th, 2021
Grant Support
- Improved Strategies For Outpatient Opioid DetoxificationNational Institute On Drug Abuse2011–2012
- Predictors Of Relapse To Prescription Opioid Abuse Among Pain PatientsNational Institute On Drug Abuse2006–2010
- Opiate Dependence: Combined Naltrexone/Behavior TherapyNational Institute On Drug Abuse2007–2008
- Predictors Of Relapse To Prescription Opioid AbuseNational Institute On Drug Abuse2005
- Opiate And Nicotine Dependence--Medications And TherapyNational Institute On Drug Abuse1999–2003
- Cultural Meanings Of Depression &AlcoholismNational Institute Of Mental Health1989
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: